SBSB
PFE icon

Sullivan, Bruyette, Speros & Blaney’s Pfizer PFE Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$3.86M Buy
106,585
+5,206
+5% +$185K 0.17% 43
2020
Q4 		$3.73M Sell
101,379
-4,513
-4% -$166K 0.17% 40
2020
Q3 		$3.69M Buy
105,892
+4,670
+5% +$164K 0.21% 35
2020
Q2 		$3.14M Sell
101,222
-2,160
-2% -$73.4K 0.19% 35
2020
Q1 		$3.2M Sell
103,382
-1,058
-1% -$36.1K 0.22% 33
2019
Q4 		$3.88M Sell
104,440
-115
-0.1% -$4.1K 0.22% 31
2019
Q3 		$3.56M Buy
104,555
+983
+0.9% +$35.7K 0.21% 29
2019
Q2 		$4.26M Buy
103,572
+1,878
+2% +$74.6K 0.26% 29
2019
Q1 		$4.1M Buy
101,694
+4,438
+5% +$178K 0.25% 28
2018
Q4 		$4.03M Buy
97,256
+1,383
+1% +$57.4K 0.28% 27
2018
Q3 		$4.01M Sell
95,873
-163
-0.2% -$6.28K 0.36% 19
2018
Q2 		$3.31M Sell
96,036
-1,065
-1% -$36.4K 0.32% 20
2018
Q1 		$3.27M Sell
97,101
-276
-0.3% -$9.49K 0.32% 19
2017
Q4 		$3.35M Sell
97,377
-840
-0.9% -$28.6K 0.32% 19
2017
Q3 		$3.33M Buy
98,217
+1,860
+2% +$59.8K 0.33% 19
2017
Q2 		$3.07M Buy
96,357
+756
+0.8% +$23.8K 0.31% 21
2017
Q1 		$3.1M Sell
95,601
-4,273
-4% -$135K 0.31% 21
2016
Q4 		$3.08M Buy
99,874
+596
+0.6% +$18.2K 0.32% 21
2016
Q3 		$3.19M Sell
99,278
-502
-0.5% -$16.8K 0.32% 21
2016
Q2 		$3.33M Buy
+99,780
New +$3.18M 0.35% 21

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Sullivan, Bruyette, Speros & Blaney's PFE Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney increased its Pfizer (PFE) stake by 5.1% in Q1 2021, buying an estimated $185K and bringing the position to 106,585 shares worth $3.86M. The position accounts for 0.17% of the portfolio, ranked #43.

Sullivan, Bruyette, Speros & Blaney first reported a position in PFE in Q2 2016 and has held it in 20 quarters since. The position peaked at $4.26M in Q2 2019. 2,676 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 106,585 shares of Pfizer worth $3.86M as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney bought 5,206 Pfizer shares in Q1 2021, an estimated $185K.
  • Pfizer made up 0.17% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #43 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Pfizer in Q2 2016 and has held it in 20 quarters since.
  • Sullivan, Bruyette, Speros & Blaney's Pfizer position peaked at $4.26M in Q2 2019.
  • 2,676 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.